Through a group of hospitals and community services, CMFT provides healthcare across Greater Manchester and the North West. With an annual turnover of over £850 million, the Trust sees over one million patients each year. In addition to providing secondary care services to local populations, CMFT provides a wide range of specialist and nationally commissioned services to the population of the North West. Throughout the North West, the Trust has the largest number of undergraduates and clinical staff in training and holds the biggest research portfolio.
2009 marked a major landmark in the Trust’s history, with the opening of four new hospitals. This was part of a £500 million redevelopment, which has provided state-of-the-art facilities including a 10,000m² embedded research space. These facilities were officially opened by Her Majesty the Queen and His Royal Highness the Duke of Edinburgh on 23rd March 2012.
Through an innovative competitive process, CMFT successfully acquired Trafford NHS Hospitals Trust, effective from April 2012. They have also established a strategic partnership with Alder Hey Children’s Hospital Foundation Trust to deliver a full range of co-ordinated, excellent secondary and tertiary care services to children across the North West of England and beyond.
CMFT’s secondary care and specialist services are delivered through: Manchester Royal Infirmary; Manchester Royal Eye Hospital; Royal Manchester Children’s Hospital; Saint Mary’s Hospital; The University Dental Hospital, Manchester; and Trafford Hospitals (Trafford, Altrincham and Stretford Memorial Hospitals).
The Trust also manages 45 community services including Adult Services e.g. District Nursing, Continence and Podiatry for the central Manchester area, along with Children's services, Contraception and Sexual Health, Community Dentistry, and Learning Disabilities services for the whole of the city.
Royal Manchester Children’s Hospital is the UK’s largest Children’s Hospital. It has the largest specialist Paediatric burns unit in the country, the first of its kind in the UK when it opened in 1953. The Paediatric Intensive Care Unit (PICU) is the largest general PICU in the UK.
Manchester Royal Infirmary provides services to the local community and a wide range of specialist services to patients from across the North West. Amongst many milestones, they have performed over 1,000 cochlear implants and 4,000 kidney transplants. They provide specialist services to Adults with Congenital Heart Disease, and numerous other specialist medical and surgical services.
The Manchester Royal Eye Hospital is one is one of only two specialist eye hospitals in the UK, with a full range of specialist services for patients with eye diseases. It is one of only two centres in the UK to take part in the Bionic Eye trial, in which 32 patients worldwide participated.
Saint Mary’s Hospital now delivers over 7,000 babies each year. The Hospital has the only Genetics service and the only surgical centre for new-born babies in the region. It was the first NHS IVF unit in the country. The Saint Mary’s Centre was the first Sexual Assault Referral Centre to be launched in the country.
In December 2011, CMFT was accredited NHSLA Level 3 for all their services.
CMFT is a member of the Manchester Academic Health Science Centre (MAHSC), a federation between the University of Manchester and five other NHS Trusts. The federation is driving the development of Greater Manchester as a world leader in health research and translational research into healthcare practice.
In 2011/12 789 clinical research studies were underway at CMFT, with over 8000 patients recruited to participate in research. A total of 831 research papers were published and £14.5 million in external research funding was awarded to our researchers.
In partnership with The University of Manchester, the Trust was awarded £4.9 million by the National Institute for Health Research (NIHR) in 2012 to set up the Musculoskeletal Biomedical Research Unit, one of the country’s flagship translational research units.
In 2012 the Wellcome Trust Clinical Research Facility, based at the Trust, was awarded £5.5 million by NIHR to expand its world class Experimental Medicine in areas of high priority and unmet need for adults and children.
In partnership with a major private sector organisation, the Trust is developing a new 100,000 sq ft bio health innovation centre to create the capacity to commercialise high quality research from Manchester to produce new devices, diagnostics and healthcare systems that will benefit patients.
The Trust’s first two spin out companies based solely on NHS intellectual property have been established and have received Technology Strategy Board SBRI investment, EPSRC Case funding and local Trusts and VC funding to accelerate their product developments.
Saint Mary’s has one of the largest clinical genetics departments in the UK and hosts one of two National Genetics Reference Laboratories which help evaluate new technologies and improve the safety and efficiency of genetic testing.
The Manchester Royal Infirmary renal team was the first winner of the NHS Innovation Challenge Prize in 2011. Their innovative redesign of dialysis, which introduced machines designed for the home, is estimated to make an annual saving of approximately £1 million based on 70 patients receiving home dialysis, and makes CMFT the only organisation in the UK to exceed the target home dialysis rate.
In 2012 The Cleft Collective, an £11 million five-year programme funded by The Healing Foundation, launched as the single biggest investment in cleft lip and palate research anywhere in the world. The programme will be led by the Universities of Manchester and Bristol in partnership with CMFT and three other organisations.
Chief Executive: Mike Deegan CBE
Mike Deegan is Chief Executive of Central Manchester and Manchester Children's University Hospitals NHS Trust. He is currently a member of the National Leadership Network and chairs its programme of work on local hospitals. Throughout 2003/04 he chaired the Modernisation Agency Steering Group on behalf of the National Modernisation Board.
Prior to his current appointment, he was Chief Executive of North Cheshire Hospitals NHS Trust and led the merger of Warrington and Halton Hospitals.